The enteral nutrition market size is expected to grow from US$ 8,276.93 million in 2022 to US$ 13,204.19 million by 2030; it is estimated to grow at a CAGR of 6.0% during 2022–2030. The growth of the market is attributed to a rise in the
prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.
There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral nutrition market.
Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral nutrition market growth in the future.
Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients’ health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products.
Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral nutrition market.
Age Group -Based Insights
Based on age group, the enteral nutrition market is categorized into adult and pediatric. In 2022, the adult segment held the largest market share. However, the pediatric segment is anticipated to record a CAGR of 6.8% during 2022–2030. A standard tube-feeding formula is designed for adults who have regular digestion. They also contain added ingredients such as fibers for better digestive health and bowel management. Like standard formulas, peptide formulas are nutritionally complete. However, unlike standard formulas, some components of peptide formulas, such as proteins, are broken down into smaller components to make them easier to digest and absorb. The easy digestibility and absorption highlight the suitability of peptide formulas in adults with digestive problems, including short bowel syndrome, inflammatory bowel disease, malabsorption, and cystic fibrosis. Specialized disease-specific enteral formulas are available for adults with special nutritional needs, such as diabetes, kidney failure, respiratory disease, or liver disorders. Several adult enteral medical nutrition formulas are available in the market. The main ingredients of medical nutritional formulas are lipid emulsions, dextrose, amino acids, vitamins, electrolytes, minerals, and trace elements. These active ingredients help prevent villous atrophy and promote the local immune function of the gut. Elecare by Ross is one of the tube-feeding formulas approved for adults. ELECARE is indicated for the dietary management of protein maldigestion, malabsorption, severe food allergies, short-bowel syndrome, and eosinophilic GI disorders, among others.
The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral nutrition market report.